The Next Big Biological Breakthrough
Unlike most conventional therapeutic pipelines which use the power of small molecules to target proteins, or more modern pipelines grappling with the limitations of oligonucleotides to tap the huge potential of targeting RNAs, we are combining the best of both worlds by developing small molecule drugs that directly target cellular RNAs to thereby correct the levels of their encoded, disease-causing proteins.